enow.com Web Search

  1. Ads

    related to: how long before vraylar works for depression prevention program

Search results

  1. Results from the WOW.Com Content Network
  2. Cariprazine - Wikipedia

    en.wikipedia.org/wiki/Cariprazine

    Cariprazine, sold under the brand name Vraylar among others, is an atypical antipsychotic developed by Gedeon Richter, [8] which is used in the treatment of schizophrenia and bipolar disorder. [9] It is also prescribed as an add-on treatment for bipolar depression [ 10 ] and major depressive disorder . [ 6 ]

  3. Antipsychotic - Wikipedia

    en.wikipedia.org/wiki/Antipsychotic

    Long-term use can produce adverse effects such as tardive dyskinesia, tardive dystonia, and tardive akathisia. First-generation antipsychotics (e.g., chlorpromazine , haloperidol , etc.), known as typical antipsychotics , were first introduced in the 1950s, and others were developed until the early 1970s. [ 12 ]

  4. List of psychotropic medications - Wikipedia

    en.wikipedia.org/wiki/List_of_psychotropic...

    Desyrel – an atypical antidepressant used to treat depression and insomnia Desoxyn ( methamphetamine hydrochloride) – used to treat attention deficit hyperactivity disorder and exogenous obesity Dexedrine ( dextroamphetamine sulfate) – used to treat attention deficit hyperactivity disorder and narcolepsy

  5. Bristol Myers wins US FDA approval for new type of ...

    www.aol.com/news/us-fda-approves-bristol-myers...

    By Bhanvi Satija and Michael Erman (Reuters) -The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the first new type of ...

  6. Prevention of mental disorders - Wikipedia

    en.wikipedia.org/wiki/Prevention_of_mental_disorders

    In 2009 the US National Academies publication on preventing mental, emotional, and behavioral disorders among young people focused on recent research and program experience and stated that "A number of promotion and prevention programs are now available that should be considered for broad implementation."

  7. AbbVie (ABBV) Q4 2024 Earnings Call Transcript - AOL

    www.aol.com/finance/abbvie-abbv-q4-2024-earnings...

    This robust performance is driven by continued double-digit growth of Vraylar with global sales of $924 million, Botox Therapeutic with global revenues of $873 million, Ubrelvy with global sales ...

  1. Ads

    related to: how long before vraylar works for depression prevention program